BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1527858)

  • 21. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
    Doranz BJ; Baik SS; Doms RW
    J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
    Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
    J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides.
    Batinić D; Robey FA
    J Biol Chem; 1992 Apr; 267(10):6664-71. PubMed ID: 1551875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
    Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
    J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid).
    Choe HR; Sodroski J
    J Virol; 1995 May; 69(5):2801-10. PubMed ID: 7707502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.
    Missé D; Cerutti M; Schmidt I; Jansen A; Devauchelle G; Jansen F; Veas F
    J Virol; 1998 Sep; 72(9):7280-8. PubMed ID: 9696823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
    Derdeyn CA; Decker JM; Sfakianos JN; Wu X; O'Brien WA; Ratner L; Kappes JC; Shaw GM; Hunter E
    J Virol; 2000 Sep; 74(18):8358-67. PubMed ID: 10954535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of human immunodeficiency virus type 1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120.
    Willey RL; Martin MA
    J Virol; 1993 Jun; 67(6):3639-43. PubMed ID: 8497072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A trans-dominant mutation in human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 inhibits membrane fusion when expressed in target cells.
    Elson HF; Dimitrov DS; Blumenthal R
    Mol Membr Biol; 1994; 11(3):165-9. PubMed ID: 7742881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity.
    Thali M; Olshevsky U; Furman C; Gabuzda D; Li J; Sodroski J
    J Virol; 1991 Sep; 65(9):5007-12. PubMed ID: 1870209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo.
    Etemad-Moghadam B; Sun Y; Nicholson EK; Fernandes M; Liou K; Gomila R; Lee J; Sodroski J
    J Virol; 2000 May; 74(9):4433-40. PubMed ID: 10756060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4.
    Werner A; Levy JA
    J Virol; 1993 May; 67(5):2566-74. PubMed ID: 8474162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions.
    Finzi A; Xiang SH; Pacheco B; Wang L; Haight J; Kassa A; Danek B; Pancera M; Kwong PD; Sodroski J
    Mol Cell; 2010 Mar; 37(5):656-67. PubMed ID: 20227370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (v3) of gp120 are chemically distinct.
    Lederman S; Bergmann JE; Cleary AM; Yellin MJ; Fusco PJ; Chess L
    AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1599-610. PubMed ID: 1457206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity.
    Mathys L; François KO; Quandte M; Braakman I; Balzarini J
    PLoS One; 2014; 9(6):e101181. PubMed ID: 24967714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
    J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
    Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
    Virology; 1992 Mar; 187(1):233-41. PubMed ID: 1736526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
    Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
    J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.